SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the
Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) August 3, 2004
EPOCH BIOSCIENCES, INC.
(Exact name of Registrant as specified in charter)| | | | | |
| Delaware | | 0-22170 | | 91-1311592 |
|
| (State or other jurisdiction of incorporation) | | (Commission
File Number) | | (I.R.S. Employer Identification No.) |
| | | | | |
| 21720 23rd Drive S.E., Suite 150, Bothell, Washington | | | 98021 | |
|
| (Address of principal executive offices) | | (Zip Code) |
Registrant’s telephone number, including area code (425) 482-5555
(Former name or former address, if changed, since last report.)
TABLE OF CONTENTS
Item 7. Exhibits
| | | |
| Exhibit | | |
Number
| | |
| 99.1 | | Transcript of Conference Call held August 3, 2004 |
Item 12. Results of Operations and Financial Condition.
On August 3, 2004, Epoch Biosciences, Inc. held a conference call with analysts and investors, the transcript of which is furnished as Exhibit 99.1 and is incorporated herein by reference.
The information in this Current Report on Form 8-K, including Exhibit 99.1, is furnished pursuant to Item 12 and shall not be deemed “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such a filing.
2
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned thereunto duly authorized.
| | | | | |
| | EPOCH BIOSCIENCES, INC.
| |
| Date: August 12, 2004 | By: | /s/ Bert W. Hogue | |
| | | Bert W. Hogue | |
| | | Vice President and Chief Financial Officer | |
EXHIBIT INDEX
The following exhibits are attached hereto and incorporated herein by reference:
| | | |
| Exhibit | | |
Number
| | |
| 99.1 | | Transcript of Conference Call held August 3, 2004 |
